Literature DB >> 35653114

"Age is just a number"; frailty as a marker of peri-operative risk in head and neck surgery: Systematic review and meta-analysis.

Eoin F Cleere1,2, Matthew G Davey3, James P O'Neill1,2.   

Abstract

BACKGROUND: Frailty refers to a patient's reduced capacity to withstand stressors due to a reduction in physiologic reserves. We assessed the impact of frailty on outcomes following head and neck surgery.
METHODS: We performed a systematic review in accordance with the PRISMA guidelines. Meta-analysis was performed using the Mantel-Haenszel method.
RESULTS: Fourteen studies incorporating 182 059 patients were included in qualitative synthesis with 15 953 (8.8%) of patients deemed as frail. Meta-analysis incorporating nine studies demonstrated that frailty is associated with an increased 30 day postoperative morbidity (OR 2.74; 95% CI 1.98-3.80; p < 0.01) and meta-analysis with six studies suggested increased 30-day mortality (OR 2.94; 95% CI 2.62-3.31; p < 0.01). Preliminary meta-analyses between two and five studies suggested that frail patients had reduced overall survival and were more likely to be discharged to a nonhome location or readmitted within 30 days.
CONCLUSIONS: Frailty appears to be associated with poor short-term outcomes following head and neck surgery and may improve understanding of an individual patient's peri-operative risk.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  elderly; frailty; head and neck; morbidity; oncogeriatrics

Mesh:

Year:  2022        PMID: 35653114     DOI: 10.1002/hed.27110

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.821


  1 in total

1.  Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery.

Authors:  Viktor Kunz; Gunnar Wichmann; Theresa Wald; Markus Pirlich; Veit Zebralla; Andreas Dietz; Susanne Wiegand
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.